A meta-analysis of mammographic screening with and without clinical breast examination

Cancer Science

Volumn 106, Issue 7, 2015, Pages 812-818

  Hamashima, Chisato ^a   Ohta, Koji ^b   Kasahara, Yoshio ^c   Katayama, Takafumi ^d   Nakayama, Tomio ^e   Honjo, Satoshi ^f   Ohnuki, Koji ^g  

^a NATIONAL CANCER CENTER   (Japan)

^b Fukui Prefectural Hospital   (Japan)

^c FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^d UNIVERSITY OF HYOGO   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^f FUKUOKA NATIONAL HOSPITAL   (Japan)

^g Iwate Prefectural Central Hospital   (Japan)

Author keywords

Breast cancer; Cancer screening; Mammography; Meta analysis; Review

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL BREAST EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BREAST TUMOR; EARLY DIAGNOSIS; MASS SCREENING; MORTALITY; RADIOGRAPHY; SURVIVAL;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; SURVIVAL ANALYSIS;

EID: 84936985957     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12693     Document Type: Review

References (44)

1. National Cancer Center. Center for Cancer Control and Information Services. Estimation of cancer incidence. [Cited 26 Feb 2015.] Available from URL: http://ganjoho.ncc.go.jp/professional/statistics/index.html
2. Oshima A. A critical review of cancer screening programs in Japan. Int J Technol Assess Health Care 1994; 10: 346-58.
3. Hisamichi S. Guidelines for cancer screening programs. Tokyo: Japan Public Health Association, 2000; (in Japanese.).
4. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727-37.
5. The Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011; 183: 1991-2001.
6. International Agency for Research on Cancer. Cancer screening in the European Union: report on the implementation of the Council Recommendation on cancer screening. Lyon. 2008.
7. Hamashima C, Saito H, Nakayama T, Nakayama T, Sobue T. The standardized development method of the Japanese guidelines for cancer screening. Jpn J Clin Oncol 2008; 38: 288-95.
8. Gøtzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013; (6): CD001877.
9. National Cancer Center. Center for Cancer Control and Information Services. Cancer Statistics 2012. [Cited26 Feb 2015.] Available from URL: http://ganjoho.jp/data/professional/statistics/backnumber/2012/cancer_statistics_2012.pdf
10. Kasahara Y, Tsuji I, Ichimura M et al. Anuual Report 2011 on Breast Cancer Screening in Japan. J Jpn Assoc Breast Cancer Screening 2012; 21: 48-58.
11. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr 1997; 22: 63-7.
12. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 2002; 359: 909-19.
13. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147: 1477-88.
14. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-9.
15. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014; 348: g366.
16. Tabar L, Fagerberg G, Chen HH et al. Efficacy of breast-cancer screening by age - New results from the Swedish Two-County Trial. Cancer 1995; 75: 2507-17.
17. Tabár L, Fagerberg CJ, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-32.
18. Duffy SW, Tabar L, Vitak B et al. The Swedish Two-County Trial of mammographic screening: cluster randomization an d end point evaluation. Ann Oncol 2003; 14: 1196-8.
19. Tabar L, Vitak B, Chen HH, Prevost TC, Duffy SW. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results. Swiss Surg 1999; 5: 199-204.
20. Tabar L, Duffy SW, Yen MF et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen 2002; 9: 159-62.
21. Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91: 1724-31.
22. Duffy SW, Tabar L, Olsen AH et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17: 25-30.
23. Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49-56.
24. Frisell J, Lidbrink E, Hellström L, Rutqvist LE. Follow-up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45: 263-70.
25. Bjurstam N, Björneld L, Duffy SW et al. The Gothenburg Breast Screening Trial - first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997; 80: 2091-9.
26. Bjurstam N, Björneld L, Warwick J et al. The Gothenburg Breast Screening Trial. Cancer 2003; 97: 2387-96.
27. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006; 368: 2053-60.
28. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst 1986; 77: 317-20.
29. Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet 1999; 353: 1903-8.
30. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147: 1459-76.
31. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002; 137: 305-12.
32. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Breast Cancer Screening. Lyon: IARC Press, 2002; 64-72.
33. Sankaranarayanan R, Ramadas K, Thara S et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011; 103: 1476-80.
34. Boulos S, Gadallah M, Neguib S et al. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast 2005; 14: 340-6.
35. Shibata A, Takahashi T, Ohuchi N, Fukao A. Evaluation of service screening for breast cancer by clinical breast examination using regional cancer registry data. Jpn J Public Health 2005; 52: 128-36.
36. Honjo S, Ando J, Tsukioka T et al. Relative and combined performance of mammography and ultrasonography for breast cancer screening in the general population: a pilot study in Tochigi Prefecture, Japan. Jpn J Clin Oncol 2007; 37: 715-20.
37. Uchida K, Yamashita A, Kawase K, Kamiya K. Screening ultrasonography revealed 15% of mammographically occult breast cancers. Breast Cancer 2008; 15: 165-8.
38. Kanemura S, Tsuji I, Ohuchi N et al. A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan. Jpn J Cancer Res 1999; 90: 607-13.
39. Sloan DA, Donnelly MB, Plymale MA et al. Improving residents' clinical skills with the structured clinical instruction module for breast cancer: results of a multiinstitutional study. Breast Cancer Education Working Group. Surgery 1997; 122: 324-33.
40. Lee KC, Dunlop D, Dolan NC. Do clinical breast examination skills improve during medical school? Acad Med 1998; 73: 1013-9.
41. Ishida T, Suzuki A, Kawai M et al. A randomized controlled trial to verify the efficacy of the use of ultrasonography in breast cancerscreening aged 40-49 (J-START): 76 196 women registered. Jpn J Clin Oncol 2014; 44: 134-40.
42. Morimoto T, Sasa M, Yamaguchi T, Kondo H, Akaiwa H, Sagara Y. Breast cancer screening by mammography in women aged under 50 years in Japan. Anticancer Res 2000; 20: 3689-94.
43. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108: 2205-40.
44. Paci E1, EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012; 19: S5-13.